This NDC is on FDA's drug shortage list (posted Jul 14, 2023)

Reported reason: Shortage of an active ingredient

Product Information

LISDEXAMFETAMINE 50 MG CAPSULE is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $2.7280 per EA under NDC 42858016501. Its NADAC has been published 134 times since Apr 24, 2024.

FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 50 MG CAPSULE

LISDEXAMFETAMINE DIMESYLATE
$2.7280per EA
DEA Schedule CII

Strength

50 mg/1

NDC

42858016501

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215330

FDA Approved

8/25/2023

TE Code

AB

On Market Since

1/30/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 50 MG CAPSULE has been published 134 times since Apr 24, 2024, and over the history we have for it it has risen 9.6%. The table below summarizes its recorded NADAC range and movement.

Current price$2.7280 per EA
All-time high$5.4397 (Oct 16, 2024)
All-time low$2.4881 (Apr 24, 2024)
52-week high$3.2484
52-week low$2.6398
Median price$3.5619
Average price$3.7507
Largest weekly change+45.4% (Jun 19, 2024)
Weeks tracked134
Tracking sinceApr 24, 2024

Price History

1W

0.0%

1M

+3.3%

3M

-1.3%

6M

-2.3%

1Y

-19.5%

3Y

N/A

5Y

N/A

All

+9.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 50 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 50 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $2.7280 per EA (NDC 42858016501), effective Nov 11, 2026.

How has the price of LISDEXAMFETAMINE 50 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 50 MG CAPSULE has risen 9.6%. It has been tracked across 134 weekly CMS publications since Apr 24, 2024.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 50 MG CAPSULE?

Since Apr 24, 2024, the NADAC for LISDEXAMFETAMINE 50 MG CAPSULE has ranged from a low of $2.4881 (Apr 24, 2024) to a high of $5.4397 (Oct 16, 2024), with a median of $3.5619 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 50 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 50 MG CAPSULE?

LISDEXAMFETAMINE 50 MG CAPSULE (NDC 42858016501) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.

Is LISDEXAMFETAMINE 50 MG CAPSULE in shortage?

Yes — NDC 42858016501 is currently listed in FDA's drug shortage database (posted Jul 14, 2023). Reported reason: Shortage of an active ingredient.